IP Library Granted Patent US 10,080,733
Granted Patent B2
US 10,080,733 · App. 15/782,128 · Granted Sep 25, 2018

Prodrugs of fumarates and their use in treating various diseases

Inventors: Tarek A. Zeidan (Lexington, MA); Scott Duncan (Bedford, MA); Christopher P. Hencken (Boston, MA); Thomas Andrew Wynn (Lexington, MA); Carlos N. Sanrame (Lexington, MA)
Assignee: Alkermes Pharma Ireland Limited
A61K31/225C07C219/08C07C229/16C07C233/18C07C233/91C07C317/18C07C317/28C07D207/06C07D207/40C07D209/52C07D211/06C07D211/38C07D295/088C07D491/113
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,080,733
App. No.
15/782,128
Granted
Sep 25, 2018
Kind
B2
Abstract

The present invention provides compounds of formula (I), and pharmaceutical compositions thereof.

Claims (5)

1. A crystalline form of a compound having the formula:

having an X-ray powder diffraction pattern comprising peaks, in terms of degrees 2-theta±0.2 degrees, at 11.6, 21.0, 24.3, 27.4, and 27.9 when using a Cu X-ray source.

2. A pharmaceutical composition comprising a crystalline form of claim 1 and a pharmaceutically acceptable carrier.

3. A method of treating multiple sclerosis in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a crystalline form of claim 1 .

4. A method of treating multiple sclerosis in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of a composition of claim 2 .

Assignments (6)
SECURITY INTEREST Recorded Feb 13, 2026
From: ALKERMES PHARMA IRELAND LIMITED
To: JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT
Reel/Frame 074858/0405 →
RELEASE OF SECURITY INTEREST IN PATENTS PREVIOUSLY RECORDED AT REEL/FRAME (073213/0302) Recorded Feb 13, 2026
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 074858/0429 →
SECURITY INTEREST Recorded Oct 23, 2025
From: ALKERMES PHARMA IRELAND LIMITED
To: JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT
Reel/Frame 073213/0302 →
SECURITY INTEREST Recorded Mar 20, 2020
From: ALKERMES PHARMA IRELAND LIMITED
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 052914/0832 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 23, 2019
From: ZEIDAN, TAREK A.; DUNCAN, SCOTT; HENCKEN, CHRISTOPHER P.; WYNN, THOMAS ANDREW; SANRAME, CARLOS N.
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 051354/0700 →
SECURITY INTEREST Recorded Dec 4, 2018
From: ALKERMES PHARMA IRELAND LIMITED
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 047671/0386 →
Continuity (6)
Continuation 15704219 · Sep 14, 2017
Continuation 15295370 · Oct 17, 2016
Continuation 14212745 · Mar 14, 2014
Provisional Application 61934365 · Jan 31, 2014
Provisional Application 61782445 · Mar 14, 2013
Related Publication 20180042881A1 · Feb 15, 2018